A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
Clinical trial NCT07429721 · RECRUITING
Trial details
- NCT number
- NCT07429721
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-03
- Primary completion
- 2028-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.